hydroxychloroquine and palbociclib

hydroxychloroquine has been researched along with palbociclib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
He, E; Xiao, R; Zeng, R; Zhang, A; Zhao, J	1
Donahue, T; Huang, M; Ji, Y; Jiang, J; Li, J; Liao, YP; Liu, X; Meng, H; Xie, X	1

Reviews

1 review(s) available for hydroxychloroquine and palbociclib

Article	Year
Small molecules targeting cGAS-STING pathway for autoimmune disease. European journal of medicinal chemistry, 2022, Aug-05, Volume: 238 Topics: Autoimmune Diseases; Humans; Inflammation; Membrane Proteins; Nucleotidyltransferases; Signal Transduction	2022

Other Studies

1 other study(ies) available for hydroxychloroquine and palbociclib

Article	Year
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment. Nature communications, 2020, 08-25, Volume: 11, Issue:1 Topics: Animals; Apoptosis; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Disease Models, Animal; Drug Delivery Systems; Drug Synergism; Humans; Hydroxychloroquine; Mice; Nanoparticles; Pancreatic Neoplasms; Piperazines; Pyridines; Silicon Dioxide; Treatment Outcome	2020

Article

Year

Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment.

Nature communications, 2020, 08-25, Volume: 11, Issue:1

Topics: Animals; Apoptosis; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Disease Models, Animal; Drug Delivery Systems; Drug Synergism; Humans; Hydroxychloroquine; Mice; Nanoparticles; Pancreatic Neoplasms; Piperazines; Pyridines; Silicon Dioxide; Treatment Outcome

2020